期刊
CLIMACTERIC
卷 16, 期 1, 页码 147-153出版社
INFORMA HEALTHCARE
DOI: 10.3109/13697137.2012.667173
关键词
EXTRACELLULAR MATRIX; PERLECAN; PROTEOGLYCANS; ESTROGEN; ATHEROSCLEROSIS
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/11382-6]
Aim To study the effects of estrogen therapy on the expression of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) and perlecan in the vascular wall. Methods Twenty 180-day-old Wistar rats were castrated and treated 1 week later for a period of 4 weeks with one of the following: (1) placebo; (2) 0.5 mu g/day estradiol benzoate (E2B); (3) 5 mu g/day E2B; (4) 50 mu g/day E2B. A fifth group consisted of rats that had not been castrated. Following treatment, expression of MMP-2 and MMP-9 mRNA (MMP-2([RNA]) and MMP-9([RNA]), respectively) was analyzed by real-time PCR, and expression of MMP-2 (MMP-2([IH])), MMP-9 (MMP-9([IH])) and perlecan was quantified by immunohistochemistry, in carotid walls. Results There were no differences among castrated groups for MMP-2([RNA]) (p = 0.1969) and for MMP-9([RNA]) (p = 0.1828); however, a correlation was observed between E 2 B dose and MMP-9([RNA]) levels (r = 0.471, p = 0.018). Differences among groups were observed for MMP-2([IH]), MMP-9([IH]) and perlecan (p < 0.0001), wherein higher levels were observed in animals treated with estrogen therapy, correlating with E2B doses in the case of MMP-9 (r = 0.441, p = 0.026) and perlecan (r = 0.574, p = 0.005). Conclusions Estrogen therapy correlates with higher levels of MMP-2, MMP-9 and perlecan in the extracellular matrix of carotid walls in castrated rats, in a dose-dependent manner. There was a dose-response effect of E2B on the expression of MMP-9 mRNA and, possibly, MMP-2 mRNA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据